UnknownNot Applicable

VEGF in Iris Tissue in Primary Congenital Glaucoma

Egypt30 participantsStarted 2022-09

Plain-language summary

Estimation of vascular endothelial growth factor (VEGF) in iris tissue specimen in primary congenital glaucoma through Immunohistochemistry.

Who can participate

Age range1 Day – 1 Year

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * primary congenital glaucoma Exclusion Criteria: * Infants with history of previous surgery. * Secondary glaucoma. * Glaucoma associated with other congenital anomalies.

What they're measuring

VEGF

Timeframe: 6 month

Trial details

NCT IDNCT05484050

SponsorHassan Lotfy Fahmy

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-03

View on ClinicalTrials.gov More Iris trials